GemPharmatech Co., Ltd. (SHA:688046)
China flag China · Delayed Price · Currency is CNY
31.39
-3.11 (-9.01%)
Nov 16, 2026, 4:00 PM EST

GemPharmatech Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
941.08792.67686.28621.73515.67392.44
Other Revenue
0.720.720.560.450.871.34
941.8793.39686.84622.19516.55393.79
Revenue Growth
25.12%15.51%10.39%20.45%31.17%50.35%
Cost of Revenue
335.48288.94261.33202.86150.22101.27
Gross Profit
606.32504.45425.51419.33366.33292.51
Selling, General & Admin
262.58246.04239.68199.61174.76134.42
Research & Development
103.8192.0687.1396.682.9355.2
Other Operating Expenses
12.394.383.572.611.721.59
Operating Expenses
382.76352.17333.68307.91267.94196.11
Operating Income
223.56152.2891.83111.4298.3996.4
Interest Expense
-6.57-6.08-4.3-2.76-0.5-0.74
Interest & Investment Income
28.0219.3122.3928.6523.7314.43
Currency Exchange Gain (Loss)
-0.91-0.911.690.081.49-0.19
Other Non Operating Income (Expenses)
-24.11-15.64-21.56-20.92-11.32-16.05
EBT Excluding Unusual Items
219.99148.9690.06116.48111.893.84
Gain (Loss) on Sale of Investments
-0.340.692.342.73-0.050.32
Gain (Loss) on Sale of Assets
-0-0.040.01-0.02-0.10.05
Asset Writedown
-3.35-----
Other Unusual Items
18.4315.326.842.162.0349.1
Pretax Income
234.73164.92119.22161.29173.68143.31
Income Tax Expense
31.8822.299.42.379.0218.39
Earnings From Continuing Operations
202.85142.64109.82158.91164.67124.93
Net Income
202.85142.64109.82158.91164.67124.93
Net Income to Common
202.85142.64109.82158.91164.67124.93
Net Income Growth
66.95%29.88%-30.89%-3.49%31.81%63.45%
Shares Outstanding (Basic)
406408407407392357
Shares Outstanding (Diluted)
406408407407392357
Shares Change
0.23%0.19%-0.18%3.93%9.84%-1.93%
EPS (Basic)
0.500.350.270.390.420.35
EPS (Diluted)
0.500.350.270.390.420.35
EPS Growth
66.56%29.63%-30.77%-7.14%20.00%66.67%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
260.97122.04-23.36-89.33-84.3324.24
Free Cash Flow Per Share
0.640.30-0.06-0.22-0.210.07
Dividend Per Share
0.3500.2200.1400.1600.041-
Dividend Growth
218.18%57.14%-12.50%290.24%--
Gross Margin
64.38%63.58%61.95%67.40%70.92%74.28%
Operating Margin
23.74%19.19%13.37%17.91%19.05%24.48%
Profit Margin
21.54%17.98%15.99%25.54%31.88%31.72%
Free Cash Flow Margin
27.71%15.38%-3.40%-14.36%-16.33%6.16%
EBITDA
296.62225.7165.73157.42135.68125.2
EBITDA Margin
31.50%28.45%24.13%25.30%26.27%31.80%
D&A For EBITDA
73.0673.4273.94637.2928.81
EBIT
223.56152.2891.83111.4298.3996.4
EBIT Margin
23.74%19.19%13.37%17.91%19.05%24.48%
Effective Tax Rate
13.58%13.51%7.88%1.47%5.19%12.83%
Revenue as Reported
941.8793.39686.84622.19516.55393.79
Advertising Expenses
-1.782.934.698.942.87